Ironwood and Allergan Initiate Phase IIb Clinical Trial of Linaclotide Colonic Release in Adults with Irritable Bowel Syndrome with Constipation
Go back to Ironwood and Allergan Initiate Phase IIb Clinical Trial of Linaclotide Colonic Release in Adults with Irritable Bowel Syndrome with Constipation| Allergan Inc (NYSE: AGN) | Delayed: 193.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $193.02 | 52 Week High | $322.68 | |||
| Open | $15.33 | 52 Week Low | $186.34 | |||
| Day High | $193.02 | P/E | 45.96 | |||
| Day Low | $193.02 | EPS | $4.20 | |||
| Volume | 43,377 | |||||
| IRONWOOD PHARMA-A (NASDAQ: IRWD) | Delayed: 3.82 +0.28 (7.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.54 | 52 Week High | $16.89 | |||
| Open | $3.60 | 52 Week Low | $7.35 | |||
| Day High | $3.91 | P/E | N/A | |||
| Day Low | $3.57 | EPS | $-2.35 | |||
| Volume | 2,522,941 | |||||
